Impact of the Spread of COVID-19 on Business Activities and Demand
First written in FY2020. 9 of 17 entries say "Restated". Latest entry: FY2024.
The whole theme swung hardest in 2020: 103 of 175 companies on the "Worse" side.
- FY2024DroppedAnnual report
「Natural disasters and infectious disease risks could cause significant losses for our small Group. To ensure business continuity, we are developing and reviewing business continuity plans (BCPs) for our factories and major domestic offices.」
The current year's annual securities report no longer contains the disclosures, which had been explicit through the previous quarter, regarding the timing of the end of the COVID-19 pandemic and its impact on all segments. Infectious diseases are described as a general business continuity risk. - FY2024-Q3RestatedAnnual report
「The timing of the end of the COVID-19 pandemic remains uncertain, and it is difficult to quantitatively forecast its impact. Based on the latest information available at this time, however, we expect the impact to continue throughout the fiscal year ending March 2024 across all segments.」
The timing of the end of the COVID-19 pandemic remains uncertain, and we continue to expect its impact on all segments to persist throughout the fiscal year ending March 2024. - FY2024-Q2RestatedAnnual report
「The timing of the end of the COVID-19 pandemic remains uncertain, and it is difficult to quantitatively forecast its impact. Based on the latest information available at this time, however, we expect the impact to continue for a certain period during the fiscal year ending March 2024 across all segments.」
The timing of the end of the COVID-19 pandemic remains uncertain, and we continue to expect its impact on all segments to persist for a certain period during the fiscal year ending March 2024. - FY2024-Q1RestatedAnnual report
「In addition, the timing of the end of the COVID-19 pandemic remains uncertain, and it is difficult to quantitatively forecast its impact. Based on the latest information available at this time, however, we expect the impact to continue for a certain period during the fiscal year ending March 2024 across all segments.」
The timing of the end of the COVID-19 pandemic remains uncertain, and we continue to expect its impact on all segments to persist for a certain period during the fiscal year ending March 2024. - FY2023WorsenedAnnual report
「Although it is extremely difficult to quantitatively forecast the impact of the COVID-19 pandemic, based on the latest information available at this time, we expect the impact to continue for a certain period during the fiscal year ending March 2024 across all segments.」
The expected period of the COVID-19 pandemic's continuing impact was extended from the fiscal year ending March 2023 to a certain period during the fiscal year ending March 2024. - FY2023-Q3RestatedAnnual report
「In addition, the timing of the end of the COVID-19 pandemic remains uncertain, and it is difficult to quantitatively forecast its impact. Based on the latest information available at this time, however, we expect the impact to continue throughout the fiscal year ending March 2023 across all segments.」
The timing of the end of the COVID-19 pandemic remains uncertain, and we continue to expect its impact on all segments to persist throughout the fiscal year ending March 2023. - FY2023-Q2RestatedAnnual report
「The timing of the end of the COVID-19 pandemic remains uncertain, and it is difficult to quantitatively forecast its impact. Based on the latest information available at this time, however, we expect the impact to continue for a certain period during the fiscal year ending March 2023 across all segments.」
The timing of the end of the COVID-19 pandemic remains uncertain, and we continue to expect its impact on all segments to persist for a certain period during the fiscal year ending March 2023. - FY2023-Q1RestatedAnnual report
「The timing of the end of the COVID-19 pandemic remains uncertain, and it is difficult to quantitatively forecast its impact. Based on the latest information available at this time, however, we expect the impact to continue for a certain period during the fiscal year ending March 2023 across all segments.」
The timing of the end of the COVID-19 pandemic remains uncertain, and we continue to expect its impact on all segments to persist for a certain period during the fiscal year ending March 2023. - FY2022WorsenedAnnual report
「Although it is extremely difficult to quantify the impact of the spread of COVID-19, based on the latest information available at this time, the company expects the impact to continue across all segments for a certain period during the fiscal year ending March 2023.」
The company now expects the impact of COVID-19 to continue across all segments from the fiscal year ending March 2022 through a certain period of the fiscal year ending March 2023, extending the assumed duration of the impact. - FY2022-Q3RestatedAnnual report
「The timing of the containment of COVID-19 remains uncertain, and it is extremely difficult to quantify its impact. However, based on the latest information available at this time, the company expects the impact to continue across all segments during the fiscal year ending March 2022.」
The company maintains its expectation that the impact of COVID-19 across all segments will continue during the fiscal year ending March 2022. - FY2022-Q2RestatedAnnual report
「The timing of the containment of COVID-19 remains uncertain, and it is difficult to quantify its impact. However, based on the latest information available at this time, the company expects the impact to continue across all segments for a certain period during the fiscal year ending March 2022.」
The company maintains its expectation that the impact of COVID-19 across all segments will continue for a certain period during the fiscal year ending March 2022. - FY2022-Q1RestatedAnnual report
「The timing of the containment of COVID-19 remains uncertain, and it is difficult to quantify its impact. However, based on the latest information available at this time, the company expects the impact to continue across all segments for a certain period during the fiscal year ending March 2022.」
The timing of the containment of COVID-19 remains uncertain, and the company expects its impact across all segments to continue for a certain period during the fiscal year ending March 2022. - FY2021WorsenedAnnual report
「The timing of the containment of COVID-19 remains uncertain, and the company expects difficult business conditions to continue for the time being.」
The impact of COVID-19 is expected to extend across all segments and continue for a certain period during the fiscal year ending March 2022. In terms of actual results, sales fell 42.9% from the previous fiscal year. - FY2021-Q3WorsenedAnnual report
「The timing of the containment of COVID-19 remains uncertain, and it is difficult to quantify its impact. However, based on the latest information available at this time, the company expects the impact to continue across all segments during the fiscal year ending March 2021.」
The timing of the containment of COVID-19 remains uncertain, and the impact is expected to continue across all segments during the fiscal year ending March 2021. In addition to the expectation that the impact would continue through the second quarter, the company explicitly stated that all segments would be affected and that the impact would continue through the fiscal year. - FY2021-Q2WorsenedAnnual report
「Amid these conditions, the Group focused on securing orders while emphasizing quality and profitability, but sales declined substantially due to such factors as sluggish investment demand resulting from the COVID-19 pandemic.」
Weak investment demand caused by COVID-19 actually occurred, and sales fell 68.4% year on year. The impact is also expected to continue for a certain period during the fiscal year ending March 2021. - FY2021-Q1MaterialisedAnnual report
「In this environment, our group focused on securing orders while emphasizing quality and profitability, but sales declined significantly due to restrictions on sales activities caused by COVID-19 and weak investment demand.」
Restrictions on sales activities caused by COVID-19 and weak investment demand among customers actually occurred, resulting in sales of ¥186 million, down 56.7% year on year. - FY2020First statedAnnual report
「The spread of COVID-19 and the measures taken by countries in response may significantly constrain the business activities of our group. To prevent the spread of infection and continue business activities, our group has implemented thorough hygiene controls and measures such as staggered commuting and working from home as appropriate. However, sales may decline due to factors including weak investment demand among customers, potentially adversely affecting our group's financial condition and operating results.」
The spread of COVID-19 and measures taken by countries in response were explicitly identified as new risks that could constrain business activities, weaken customers' investment demand and lead to lower sales.